Jeffrey M. Schmidt
ORCID: 0000-0002-3715-5896
· 1 paper in corpus
article
2018
The aim of these studies was to assess the safety and pharmacokinetics of elagolix, an oral nonpeptide gonadotropin-releasing hormone antagonist following oral administration in women with renal or hepatic impairment. Two phase 1 studies we…